NEW: As expected, CDC advisers voted to:
— Leana Wen, M.D. (@DrLeanaWen) October 21, 2021
* Authorize Moderna booster (half dose) to mirror recommendations for Pfizer, 6 months after initial series
* Authorize 2nd vaccine dose for all J&J recipients, 2 months after 1st dose
* Allow mix & match boosters 👏https://t.co/L7vzQlNWGw
Explosion of new #COVID19 cases across Eastern Europe & UK. Surge so high that Latvia is forced into lockdown, and Latvia health minister blames “disinformation” about vaccines in Russian-language media for vaccine skepticism. New wave possibly restarting.https://t.co/9Ji6B2Aa2B pic.twitter.com/22FH9ihf7K
— Eric Feigl-Ding (@DrEricDing) October 21, 2021
A booster dose of the Pfizer/BioNTech vaccine was found to have a 95.6% efficacy against Covid-19 in a Phase 3 trial, the companies announced. They noted that "efficacy was consistent irrespective of age, sex, race, ethnicity or comorbid conditions."
— CNN (@CNN) October 21, 2021
https://t.co/ntTbv85QMo
The U.S. continues to do a pathetic job of tracking variant #SARSCoV2 strains. Israel, in contrast, tests & sequences #COVID19 cases aggressively. And despite triple-vaccination, the country has spotted 56 new variants in circulation.https://t.co/q5uxfeAY1D
— Laurie Garrett (@Laurie_Garrett) October 21, 2021
No comments:
Post a Comment